Christine E. Garnett, PharmD
Dr. Garnett is currently the Associate Director of Pharmacometric Operations in the Office of Clinical Pharmacology at the FDA. She received her B.S. in Biological Sciences from Florida State University and her Pharm.D. with honors from the University of Maryland. Following graduation, she worked in clinical PKPD at GloboMax, LLC. From 2002 to 2004, she was a clinical pharmacology fellow with Dr. Carl Peck in the Center for Drug Development Science at Georgetown University.
In 2005, Dr. Garnett moved into her current role at the FDA. Her main area of focus is application of modeling and simulation techniques in regulatory approval process. She has been representing clinical pharmacology on the Interdisciplinary Review Team for QT studies since September 2006 and currently serves as the Scientific Lead.
Return to Scientific Advisory Board
